Understand Your European Market Access Barriers — and Know What to Do Next

When You May Need Market Access Support

Market access support may be needed when no relevant coding or reimbursement exists, an existing tariff does not cover the cost of the technology, or access is restricted by payers or an unfavorable HTA decision.

It may also be required when different countries follow different pathways, your company must prioritize markets, or clinical and economic evidence plans need to reflect payer expectations.

What Is the Current Access Situation?

We assess procedure and device coding, payment mechanisms, reimbursement tariffs, innovation payments, national funding frameworks and HTA requirements.

What Does This Mean for Your Technology?

We determine whether reimbursement is available and adequate, whether access is restricted, what payer or HTA requirements may apply, and how the barriers differ between countries.

What Should You Do Next?

We identify feasible pathways, recommended and non-recommended options, relevant stakeholders, evidence requirements, application steps, timelines and practical next actions.

What Your Team Will Be Able to Decide

Our work helps your team decide which European markets offer the most feasible access conditions, whether the current reimbursement route is commercially viable and where a new code, tariff or payment pathway may be needed.

It also clarifies whether payer or HTA engagement is necessary, what evidence must be developed and what actions should be taken first.

Access Snapshot

For companies asking:

What is the reimbursement, payer and HTA situation today?

The assessment provides a structured view of coding, payment mechanisms, tariffs, funding pathways, payer requirements and HTA considerations. It also explains what the findings mean for your technology and highlights the main barriers and differences between countries.

Access Pathway and Action Plan

For companies asking:

What should we do to establish or improve access?

This solution combines a current-state assessment with a clear definition of the access problem, target access position, feasible pathways, stakeholder and evidence requirements, timelines and a recommended action plan.

Evidence-for-Access Planning

For companies asking:

What evidence will payers or HTA bodies expect?

We assess likely evidence expectations, identify gaps that could affect access and recommend the clinical, economic and study-planning work needed to support future payer and HTA discussions.
This may lead to an Evidence Gap Analysis, value dossier or health economic model.

How MTRC Works

Define the Technology and Business Decision

We clarify the technology, indication, patient population, care setting, target countries and the decision the work must support.

Assess the Current Access Environment

We analyze coding, payment mechanisms, reimbursement tariffs, payer conditions, policy, and HTA requirements.

Compare Countries and Identify Barriers

We determine where access conditions differ and identify the main reimbursement, payer, HTA and evidence barriers.

Evaluate Feasible Access Pathways

We assess the available options and determine which pathways are realistic for the technology in each market.

Define Requirements and Next Steps

We identify the evidence, stakeholders, applications, implementation activities and timelines required.

Present Conclusions and Practical Recommendations

We explain the findings, their implications and the actions your team should take next.

Why MTRC

Specialist MedTech Expertise

MTRC focuses on medical devices, in-vitro diagnostic tests and related medical technologies.

Our team understands that implantable devices, procedures, diagnostics, medical aids and digital technologies face different reimbursement, payer and HTA challenges.

Consistent Multi-Country Analysis

One MTRC team applies a consistent methodology across major European markets.

This gives clients a comparable view of country-specific access conditions without coordinating multiple unrelated local providers.

Access to Specialist Systems and Documentation

MTRC maintains access to coding, grouping and reimbursement tools that are not always publicly available.

These resources support a detailed assessment of procedure coding, payment mechanisms, and reimbursement tariffs.

Accumulated Country Know-How

Our team applies country-specific knowledge developed through many years of European market access consulting.

We combine established analytical methods with an understanding of how individual reimbursement and HTA systems operate in practice.

Structured Quality Control

MTRC uses work instructions, checklists, internal review processes and a structured quality-management system.

MTRC is an ISO 9001:2015-certified organization.

Current Market Intelligence

MTRC continuously tracks developments in coding, reimbursement, payment systems, policy and HTA via our Access Intelligence solution.

This monitoring infrastructure helps ensure that project findings reflect the current market access environment.

Discuss Your European Market Access Challenge

Tell us about your technology, target markets and the decision your team needs to make.

MTRC will recommend the most appropriate level of analysis and strategic support.

Discuss Your Market Access Challenge

Understand Your European Market Access Barriers — and Know What to Do Next

When You May Need Market Access Support

Three Questions We Help You Answer

Choose the Right Level of Support

How MTRC Works

Why MTRC

Discuss Your European Market Access Challenge